AnalystsAlan CarrAlan Carr's Stock Forecasts
AnalystsAlan Carr
Sectors:
Industries:
Analyst Ranking
Top 21%
#1021 out of 4875 analysts
Average Return
+16.98%
Win Rate
32%6 out of 19
Risk vs Reward
Poor
Good
Alan Carr's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +437.00% | $29.16 | $156.59 | 2020-02-26 - 2020-12-09 | Buy |
Moderna IncMRNA | +194.40% | $53.19 | $156.59 | 2020-05-07 - 2020-12-09 | Buy |
Crispr Therapeutics AgCRSP | +35.91% | $86.40 | $117.43 | 2020-07-28 - 2021-07-27 | Buy |
Albireo Pharma IncALBO | +20.31% | $27.33 | $32.88 | 2017-07-18 - 2018-07-18 | Buy |
Vertex Pharmaceuticals IncVRTX | +19.24% | $133.50 | $159.19 | 2017-06-23 - 2018-06-22 | Buy |
Alan Carr Analyst Color
Get additional color on Alan Carr's coverage of popular stocks
Alan Carr's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Vir Biotechnology IncVIR | 1 | Buy | $62.00 | N/A | Initiates Coverage On | 5 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $105.00 | N/A | Maintains | 5 years ago |
Vaxcyte IncPCVX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Intercept Pharmaceuticals IncICPT | 3 | Buy | $100.00 | N/A | Maintains | 5 years ago |
Pliant Therapeutics IncPLRX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Buy | $160.00 | N/A | Maintains | 5 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Buy | $1,250.00 | N/A | Maintains | 5 years ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $120.00 | N/A | Maintains | 5 years ago |
Iterum Therapeutics PLCITRM | 1 | Buy | $300.00 | N/A | Initiates Coverage On | 7 years ago |
Arena Pharmaceuticals IncARNA | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Genocea Biosciences IncGNCAQ | 3 | Buy | N/A | N/A | Upgrades | 7 years ago |
Albireo Pharma IncALBO | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 8 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.